DK1562954T3 - CCR1-antagonister til behandling af I.A. inflammatorisk demyelinisationssygdom - Google Patents

CCR1-antagonister til behandling af I.A. inflammatorisk demyelinisationssygdom

Info

Publication number: DK1562954T3
Authority: DK; Denmark
Prior art keywords: treatment; inflammatory demyelination; ccr1 antagonists; demyelination disease; disease
Prior art date: 2002-11-13

Application number

DK03768852T

Other languages

English (en)

Inventor

Kenneth G Carson

Geraldine C B Harriman

Shomir Ghosh

Original Assignee

Millennium Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-13

Filing date

2003-11-12

Publication date

2006-08-28

2003-11-12 Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc

2006-08-28 Application granted granted Critical

2006-08-28 Publication of DK1562954T3 publication Critical patent/DK1562954T3/da

Links

102100031172 C-C chemokine receptor type 1 Human genes 0.000 title 1
101710149814 C-C chemokine receptor type 1 Proteins 0.000 title 1
208000016192 Demyelinating disease Diseases 0.000 title 1
206010012305 Demyelination Diseases 0.000 title 1
239000005557 antagonist Substances 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
230000002757 inflammatory effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Transplantation (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK03768852T 2002-11-13 2003-11-12 CCR1-antagonister til behandling af I.A. inflammatorisk demyelinisationssygdom DK1562954T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US42594702P	2002-11-13	2002-11-13

Publications (1)

Publication Number	Publication Date
DK1562954T3 true DK1562954T3 (da)	2006-08-28

Family

ID=32313083

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03768852T DK1562954T3 (da)	2002-11-13	2003-11-12	CCR1-antagonister til behandling af I.A. inflammatorisk demyelinisationssygdom

Country Status (24)

Country	Link
US (7)	US20040106639A1 (da)
EP (2)	EP1562954B1 (da)
JP (1)	JP4644491B2 (da)
KR (1)	KR101109348B1 (da)
CN (1)	CN100343257C (da)
AR (1)	AR041942A1 (da)
AT (2)	ATE325124T1 (da)
AU (2)	AU2003291452A1 (da)
BR (1)	BR0316261A (da)
CA (1)	CA2505874C (da)
CY (1)	CY1107985T1 (da)
DE (2)	DE60305063T2 (da)
DK (1)	DK1562954T3 (da)
EA (1)	EA007748B1 (da)
ES (2)	ES2346337T3 (da)
IL (2)	IL168384A (da)
MX (1)	MXPA05005105A (da)
NO (1)	NO331855B1 (da)
PL (1)	PL211022B1 (da)
PT (1)	PT1562954E (da)
SI (1)	SI1562954T1 (da)
TW (1)	TWI291467B (da)
WO (1)	WO2004043965A1 (da)
ZA (2)	ZA200504144B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7271176B2 (en) *	1998-09-04	2007-09-18	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use thereof
US7541365B2 (en)	2001-11-21	2009-06-02	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
TWI291467B (en)	2002-11-13	2007-12-21	Millennium Pharm Inc	CCR1 antagonists and methods of use therefor
US7838522B2 (en)	2004-11-17	2010-11-23	Ares Trading S.A.	Benzothiazole formulations and use thereof
EP1841429B1 (en)	2004-12-17	2012-04-18	Millennium Pharmaceuticals, Inc.	Solid forms of a chemokine receptor antagonist and methods of use thereof
RS52193B (sr)	2004-12-21	2012-10-31	Merck Serono Sa.	Ciklični derivati sulfonil amina i njihova upotreba
UA86862C2 (en)	2005-01-31	2009-05-25	Лаборатуар Сероно С.А.	N-hydroxyamide derivatives and use thereof
KR20080044836A (ko)	2005-07-15	2008-05-21	라보라뚜와르 세로노 에스. 에이.	자궁내막증 치료용 ｊｎｋ 억제제
BRPI0613042A2 (pt)	2005-07-15	2010-12-14	Serono Lab	inibidores de jnk para o tratamento de endometriose
JP2009507003A (ja)	2005-09-01	2009-02-19	アレストレーディングソシエテアノニム	視神経炎の治療
US7601844B2 (en)	2006-01-27	2009-10-13	Bristol-Myers Squibb Company	Piperidinyl derivatives as modulators of chemokine receptor activity
KR20090020694A (ko)	2006-07-14	2009-02-26	일라이 릴리 앤드 캄파니	글루코코르티코이드 수용체 조절제 및 이의 사용 방법
EP2173713B1 (en) *	2007-07-24	2016-02-17	Bristol-Myers Squibb Company	Piperidinyl derivatives as modulators of chemokine receptor activity
US8288371B2 (en) *	2007-10-05	2012-10-16	Pharmacopeia, Llc	Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation
WO2009073462A1 (en) *	2007-11-30	2009-06-11	Millennium Pharmaceuticals, Inc.	Process for the preparation of 5-cyclopropyl-5, 11-dihydro (1) benzoxepino (3, 4-b) -pyridin-5-ol using tmeda
US20090286823A1 (en) *	2007-12-17	2009-11-19	Millennium Pharmaceuticals Inc.	CCR1 Inhibitors useful for the treatment of multiple myeloma and other disorders
EA017288B1 (ru)	2008-01-11	2012-11-30	Эли Лилли Энд Компани	(E)-N-{3-[1-(8-ФТОР-11Н-10-ОКСА-1-АЗАДИБЕНЗО[a,d]ЦИКЛОГЕПТЕН-5-ИЛИДЕН)ПРОПИЛ]ФЕНИЛ}МЕТАНСУЛЬФОНАМИД В КАЧЕСТВЕ МОДУЛЯТОРА РЕЦЕПТОРОВ ГЛЮКОКОРТИКОИДОВ ДЛЯ ЛЕЧЕНИЯ РЕВМАТИЗМА
TWI433838B (zh)	2008-06-25	2014-04-11	必治妥美雅史谷比公司	作為趨化因子受體活性調節劑之六氫吡啶衍生物
EP2771484A1 (en)	2011-10-28	2014-09-03	Galderma Research & Development	New leukocyte infiltrate markers for rosacea and uses thereof

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE80449C (da)
US377729A (en) *		1888-02-07		Half to phillips
DD80449A (da)
GB1003292A (en)	1960-12-08	1965-09-02	Sandoz Ag	Improvements in or relating to 4-azathiaxanthene derivatives
FR1332145A (da)	1961-06-08	1963-12-16
CH416624A (de)	1962-10-23	1966-07-15	Sandoz Ag	Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
NL132137C (da) *	1963-04-24
FR88751E (da)	1963-07-09	1967-06-07
GB1085406A (en)	1963-10-14	1967-10-04	Pfizer & Co C	Aminoalkylphosphorus compounds, preparation thereof and reaction products with ketones
FR145F (da)	1964-06-01
CH421138A (de)	1965-11-04	1966-09-30	Wander Ag Dr A	Verfahren zur Herstellung von Thioxanthenderivaten
US3409621A (en) *	1966-04-01	1968-11-05	Schering Corp	Piperazino-aza-dibenzo-[a, d]-cycloheptenes
US3625974A (en)	1967-04-28	1971-12-07	Fujisawa Pharmaceutical Co	Dibenzothiazepine derivatives
GB1206216A (en)	1967-07-18	1970-09-23	Pfizer & Co C	Aminopropylidene dibenzoxepine tranquilizers
NL6905642A (da)	1968-04-12	1969-10-14
JPS4830064B1 (da)	1968-12-23	1973-09-17
GB1330966A (en)	1970-12-22	1973-09-19	Yoshitomi Pharmaceutical	N-substituted piperidine compounds methods for their production and pharmaceutical compositions containing them
US3770729A (en) *	1970-12-22	1973-11-06	Yoshitomi Pharmaceutical	N substituted piperidine compounds
GB1323659A (en)	1971-04-10	1973-07-18	Yoshitomi Pharmaceutical	Piperazine derivatives methods for their production and pharmaceuticl compositions containing them
CA1010870A (en) *	1972-12-08	1977-05-24	Niels Lassen	Thiaxanthene derivative and method
US4250176A (en) *	1976-12-21	1981-02-10	Janssen Pharmaceutica N.V.	Piperazine derivatives
US4335122A (en) *	1981-03-18	1982-06-15	Hoechst-Roussel Pharmaceuticals Inc.	Dihydro-dibenzoxepines-thiepines and -morphanthridones, compositions and use
DE3326641A1 (de)	1982-07-27	1984-02-02	Basf Ag, 6700 Ludwigshafen	5,6-dihydro-11-h-morphantridin-6-one, ihre herstellung und diese enthaltende arzneimittel
CA1237428A (en) *	1983-06-24	1988-05-31	Hiroshi Tanaka	¬1\| benzepino¬3,4-b\|pyridine derivative
ES524680A0 (es)	1983-08-02	1984-12-16	Espanola Farma Therapeut	Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.
DE3402060A1 (de) *	1984-01-21	1985-08-01	Dr. Karl Thomae Gmbh, 7950 Biberach	Substituierte 5,11-dihydro-6h-dibenz(b,e)azepin-6-one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CS236549B1 (cs)	1984-02-02	1985-05-15	Miroslav Protiva	Piperazinoalkanoly dibenzo(b,e)thiepinové řady a jejich soli s kyselinou maleinovou
CS236550B1 (cs)	1984-02-02	1985-05-15	Miroslav Protiva	Způsob přípravy esterů piperazinoalkanolů dibenzo(b,e)thiepinové řady a jejich solí s kyselinou maleinovou
CS240698B1 (cs)	1984-10-12	1986-02-13	Miroslav Protiva	Substituované ll-(piperidinoalkyl)-6,ll-dihydrodibenzo (b,e)thiepin-ll-karbonitrily
JPH0665664B2 (ja)	1985-01-18	1994-08-24	大塚製薬株式会社	モルフアントリジン誘導体
SE8500273D0 (sv) *	1985-01-22	1985-01-22	Leo Ab	Nya tricykliska foreningar, kompositioner innehallande sadana foreningar, framstellningsforfaranden och behandlingsmetoder
JPS6310784A (ja)	1986-03-03	1988-01-18	Kyowa Hakko Kogyo Co Ltd	抗アレルギー剤
WO1988000049A1 (fr)	1986-06-26	1988-01-14	Kyowa Hakko Kogyo Co., Ltd.	Agent antiarythmique
US5089496A (en) *	1986-10-31	1992-02-18	Schering Corporation	Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
IT8721978A0 (it)	1987-09-21	1987-09-21	Angeli Inst Spa	Nuovi derivati ammidinici triciclici.
US4882351A (en) *	1987-10-14	1989-11-21	Roussel Uclaf	Tricyclic compounds
AU612437B2 (en) *	1987-12-14	1991-07-11	Kyowa Hakko Kogyo Co. Ltd.	Tricyclic compounds
CA1341044C (en)	1988-04-28	2000-07-04	Frank J. Villani	Benzopyrido piperidine, piperidylidene and peperazine compounds, compositions, methods of manufacture and methods of use
US4999363A (en) *	1988-06-09	1991-03-12	Kyowa Hakko Kogyo Co., Ltd.	Tricyclic compounds
US5242931A (en) *	1988-06-09	1993-09-07	Kyowa Hakko Kogyo Co., Ltd.	Tricyclic compounds as TXA2 antagonists
DE3827093A1 (de)	1988-08-10	1990-02-15	Nattermann A & Cie	Verfahren zur herstellung von hochreinem ebselen
DE3838912A1 (de) *	1988-11-17	1990-05-23	Thomae Gmbh Dr K	Mittel zur behandlung von akuten und chronischen obstruktiven atemwegserkrankungen
JPH0694464B2 (ja) *	1991-01-23	1994-11-24	協和醗酵工業株式会社	三環式化合物およびその中間体
US5239083A (en) *	1991-03-11	1993-08-24	Kyowa Hakko Kogyo Co., Ltd.	Indole derivatives which inhibit steroid 5α reductase
WO1992016226A1 (en)	1991-03-19	1992-10-01	Smithkline Beecham Corporation	Il-1 inhibitors
EP0586560A1 (en)	1991-05-23	1994-03-16	Schering Corporation	Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use
JPH06509341A (ja)	1991-07-23	1994-10-20	シェリング・コーポレーション	新規ベンゾピリドピペリジリデン化合物、組成物、製造方法および使用方法
US5378701A (en) *	1991-12-27	1995-01-03	Kyowa Hakko Kogyo	Tricyclic compounds
US5679703A (en) *	1992-09-16	1997-10-21	Kyowa Hakko Kogyo, Co., Ltd.	Tricyclic compounds having ACAT inhibiting activity
ES2250964T3 (es)	1992-11-10	2006-04-16	Genentech, Inc.	Receptor de la quimioquina c-c(c-c ckr-1).
US5538986A (en) *	1993-12-06	1996-07-23	Schering Corporation	Tricyclic derivatives, compositions and methods of use
MY113463A (en) *	1994-01-04	2002-03-30	Novo Nordisk As	Novel heterocyclic compounds
UA54385C2 (uk) *	1995-04-07	2003-03-17	Ново Нордіск А/С	N-заміщені азагетероциклічні карбонові кислоти та їх ефіри, спосіб їх одержання, фармацевтична композиція та спосіб лікування
US5712280A (en)	1995-04-07	1998-01-27	Schering Corporation	Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
AU5271096A (en)	1995-04-07	1996-10-23	Novo Nordisk A/S	Novel heterocyclic compounds
US5801175A (en) *	1995-04-07	1998-09-01	Schering Corporation	Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
WO1996031469A1 (en)	1995-04-07	1996-10-10	Novo Nordisk A/S	N-substituted azaheterocyclic carboxylic acids and esters thereof
JPH0940662A (ja)	1995-05-24	1997-02-10	Kyowa Hakko Kogyo Co Ltd	三環式化合物
CA2231773A1 (en) *	1995-09-13	1997-03-20	Shigeru Aono	Phenylpiperidine derivative
AU1208397A (en)	1995-12-28	1997-07-28	Takeda Chemical Industries Ltd.	Diphenylmethane derivatives as mip-1alpha/rantes receptor antagonists
DE29602088U1 (de)	1996-02-07	1996-04-04	Bümach Engineering International B.V., Emmen	Verschraubbarer druckmittelbetätigter Arbeitszylinder mit Verschlußteilen zur Kopplung des Zylinderrohres
US6686353B1 (en)	1996-05-20	2004-02-03	Teijin Intellectual Property Center Limited	Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
US6281212B1 (en) *	1996-07-12	2001-08-28	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
US6323206B1 (en)	1996-07-12	2001-11-27	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
WO1998004554A1 (en)	1996-07-29	1998-02-05	Banyu Pharmaceutical Co., Ltd.	Chemokine receptor antagonists
WO1998011098A1 (en)	1996-09-13	1998-03-19	Schering Corporation	Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase
EP0929544B1 (en)	1996-09-13	2004-11-10	Schering Corporation	Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
BR9712831A (pt)	1996-09-13	1999-11-16	Schering Corp	Inibidores tricìclicos de farnesil proteìna transferase
ES2169420T3 (es)	1996-09-13	2002-07-01	Schering Corp	Compuestos triciclicos utiles para inhibir la funcion de la proteina g y para tratar enfermedades proliferativas.
ES2242232T3 (es)	1996-09-13	2005-11-01	Schering Corporation	Benzocicloheptapiridinas sustituidas utiles como inhibidores de la farnesil-proteina-transferasa.
AU4337497A (en)	1996-09-13	1998-04-02	Schering Corporation	Tricyclic compounds useful as fpt inhibitors
CA2264513C (en)	1996-09-13	2004-03-30	Schering Corporation	Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase
ZA978792B (en)	1996-10-04	1998-04-06	Novo Nordisk As	N-substituted azaheterocyclic compounds.
PL332593A1 (en)	1996-10-04	1999-09-27	Novo Nordisk As	N-substituted azaheterocyclic compounds
ATE234831T1 (de)	1996-10-04	2003-04-15	Novo Nordisk As	1,4-disubstituierte piperazine
AU5803398A (en)	1996-12-13	1998-07-03	Merck & Co., Inc.	Spiro-substituted azacycles as modulators of chemokine receptor activity
AU5604998A (en)	1996-12-13	1998-07-03	Merck & Co., Inc.	Spiro-substituted azacycles as modulators of chemokine receptor activity
WO1998025617A1 (en)	1996-12-13	1998-06-18	Merck & Co., Inc.	Substituted aryl piperazines as modulators of chemokine receptor activity
US5919776A (en) *	1996-12-20	1999-07-06	Merck & Co., Inc.	Substituted aminoquinolines as modulators of chemokine receptor activity
AU5812498A (en)	1996-12-20	1998-07-17	Merck & Co., Inc.	Substituted aminoquinolines as modulators of chemokine receptor activity
WO1998043638A1 (en)	1997-03-27	1998-10-08	Kyowa Hakko Kogyo Co., Ltd.	Therapeutic agent for autoimmune diseases
BR9808552A (pt)	1997-04-15	2000-05-23	Kyowa Hakko Kogyo Kk	Composto tricìclico ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica
US5877177A (en) *	1997-06-17	1999-03-02	Schering Corporation	Carboxy piperidylacetamide tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
JP2002515914A (ja)	1997-06-25	2002-05-28	ノボノルディスクアクティーゼルスカブ	新規へテロ環式化合物
US6040318A (en)	1997-06-25	2000-03-21	Novo Nordisk A/S	Tricycle substituted with azaheterocyclic carboxylic acids
US6048856A (en) *	1997-12-17	2000-04-11	Novo Nordisk A/S	Heterocyclic compounds
US6509346B2 (en) *	1998-01-21	2003-01-21	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
ATE309249T1 (de) *	1998-01-21	2005-11-15	Millennium Pharm Inc	Chemokin rezeptor antagonisten und verwndung
WO1999037619A1 (en)	1998-01-21	1999-07-29	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
US6613905B1 (en)	1998-01-21	2003-09-02	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
US6288083B1 (en) *	1998-09-04	2001-09-11	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) *	1998-09-04	2007-09-18	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use thereof
US20020169155A1 (en) *	1998-09-04	2002-11-14	Millennium Pharmaceuticals, Inc.	Chemokine receptor anagonists and methods of use therefor
US6503926B2 (en) *	1998-09-04	2003-01-07	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
EA008060B1 (ru)	1998-09-04	2007-02-27	Милленниум Фармасьютикалз, Инк.	Антагонисты хемокинного рецептора и способы их применения
CA2343536A1 (en)	1998-09-04	2000-03-16	Yoshisuke Nakasato	Chemokine receptor antagonists and methods of use therefor
WO2000032193A1 (en)	1998-12-02	2000-06-08	Novo Nordisk A/S	Use of n-substituted azaheterocyclic compounds for the manufacture of a pharmaceutical composition for the treatment of indications related to angiogenesis
AU6503900A (en) *	1999-07-28	2001-02-19	Kyowa Hakko Kogyo Co. Ltd.	Chemokine receptor antagonists and methods of use therefor
WO2001009094A2 (en)	1999-07-28	2001-02-08	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
EP1448566B3 (en) *	2001-11-21	2009-04-08	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use thereof
TWI291467B (en)	2002-11-13	2007-12-21	Millennium Pharm Inc	CCR1 antagonists and methods of use therefor
JP4840356B2 (ja)	2005-04-20	2011-12-21	三菱電機株式会社	過電流継電器
JP4715952B2 (ja)	2009-02-18	2011-07-06	村田機械株式会社	フロッグレッグ型移載装置

2003
- 2003-11-11 TW TW92131488A patent/TWI291467B/zh not_active IP Right Cessation
- 2003-11-12 EP EP20030768852 patent/EP1562954B1/en not_active Expired - Lifetime
- 2003-11-12 ES ES06004508T patent/ES2346337T3/es not_active Expired - Lifetime
- 2003-11-12 DE DE2003605063 patent/DE60305063T2/de not_active Expired - Lifetime
- 2003-11-12 EP EP20060004508 patent/EP1669356B1/en not_active Expired - Lifetime
- 2003-11-12 WO PCT/US2003/035817 patent/WO2004043965A1/en not_active Ceased
- 2003-11-12 DE DE60332663T patent/DE60332663D1/de not_active Expired - Lifetime
- 2003-11-12 AU AU2003291452A patent/AU2003291452A1/en not_active Abandoned
- 2003-11-12 KR KR1020057008518A patent/KR101109348B1/ko not_active Expired - Fee Related
- 2003-11-12 CN CNB2003801086866A patent/CN100343257C/zh not_active Expired - Fee Related
- 2003-11-12 MX MXPA05005105A patent/MXPA05005105A/es active IP Right Grant
- 2003-11-12 EA EA200500803A patent/EA007748B1/ru not_active IP Right Cessation
- 2003-11-12 AR ARP030104145 patent/AR041942A1/es active IP Right Grant
- 2003-11-12 PT PT03768852T patent/PT1562954E/pt unknown
- 2003-11-12 US US10/706,835 patent/US20040106639A1/en not_active Abandoned
- 2003-11-12 SI SI200330325T patent/SI1562954T1/sl unknown
- 2003-11-12 JP JP2004552003A patent/JP4644491B2/ja not_active Expired - Fee Related
- 2003-11-12 BR BR0316261A patent/BR0316261A/pt not_active Application Discontinuation
- 2003-11-12 AT AT03768852T patent/ATE325124T1/de active
- 2003-11-12 AT AT06004508T patent/ATE468340T1/de not_active IP Right Cessation
- 2003-11-12 CA CA 2505874 patent/CA2505874C/en not_active Expired - Fee Related
- 2003-11-12 PL PL377715A patent/PL211022B1/pl unknown
- 2003-11-12 ES ES03768852T patent/ES2261979T3/es not_active Expired - Lifetime
- 2003-11-12 DK DK03768852T patent/DK1562954T3/da active
2005
- 2005-05-04 IL IL168384A patent/IL168384A/en not_active IP Right Cessation
- 2005-05-10 NO NO20052272A patent/NO331855B1/no not_active IP Right Cessation
- 2005-05-23 ZA ZA200504144A patent/ZA200504144B/en unknown
- 2005-08-16 US US11/204,930 patent/US20050288319A1/en not_active Abandoned
2006
- 2006-07-21 CY CY061101015T patent/CY1107985T1/el unknown
- 2006-09-20 ZA ZA2006/07868A patent/ZA200607868B/en unknown
2007
- 2007-09-13 US US11/900,744 patent/US7732459B2/en not_active Expired - Fee Related
2008
- 2008-07-03 AU AU2008202965A patent/AU2008202965B2/en not_active Ceased
2010
- 2010-04-22 US US12/765,070 patent/US7977350B2/en not_active Expired - Fee Related
- 2010-12-16 IL IL210046A patent/IL210046A/en active IP Right Grant
2011
- 2011-06-02 US US13/151,701 patent/US8394817B2/en not_active Expired - Fee Related
2013
- 2013-01-22 US US13/746,688 patent/US20130289063A1/en not_active Abandoned
2014
- 2014-02-04 US US14/172,398 patent/US9334283B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ZA200504144B (en)	2007-04-25
TW200413347A (en)	2004-08-01
ATE325124T1 (de)	2006-06-15
US20050288319A1 (en)	2005-12-29
EP1669356A1 (en)	2006-06-14
NO331855B1 (no)	2012-04-23
HK1074046A1 (en)	2005-10-28
PT1562954E (pt)	2006-07-31
EA200500803A1 (ru)	2005-10-27
NO20052272L (no)	2005-06-06
EP1562954B1 (en)	2006-05-03
AU2008202965B2 (en)	2012-03-22
AR041942A1 (es)	2005-06-01
ES2346337T3 (es)	2010-10-14
US20110230516A1 (en)	2011-09-22
US20100249174A1 (en)	2010-09-30
EA007748B1 (ru)	2006-12-29
JP4644491B2 (ja)	2011-03-02
US9334283B2 (en)	2016-05-10
JP2006508966A (ja)	2006-03-16
US7977350B2 (en)	2011-07-12
CN100343257C (zh)	2007-10-17
US8394817B2 (en)	2013-03-12
AU2008202965A1 (en)	2008-07-31
PL377715A1 (pl)	2006-02-06
DE60305063D1 (de)	2006-06-08
KR20050074609A (ko)	2005-07-18
AU2003291452A1 (en)	2004-06-03
CA2505874A1 (en)	2004-05-27
US20150005338A1 (en)	2015-01-01
IL168384A (en)	2011-01-31
HK1086011A1 (en)	2006-09-08
US20080139602A1 (en)	2008-06-12
PL211022B1 (pl)	2012-03-30
CA2505874C (en)	2012-07-17
IL210046A0 (en)	2011-07-31
ATE468340T1 (de)	2010-06-15
TWI291467B (en)	2007-12-21
ZA200607868B (en)	2008-01-08
US7732459B2 (en)	2010-06-08
EP1669356B1 (en)	2010-05-19
BR0316261A (pt)	2005-10-11
DE60332663D1 (de)	2010-07-01
EP1562954A1 (en)	2005-08-17
US20040106639A1 (en)	2004-06-03
MXPA05005105A (es)	2005-07-01
KR101109348B1 (ko)	2012-01-31
IL210046A (en)	2015-07-30
CN1738824A (zh)	2006-02-22
ES2261979T3 (es)	2006-11-16
WO2004043965A1 (en)	2004-05-27
US20130289063A1 (en)	2013-10-31
SI1562954T1 (sl)	2006-10-31
DE60305063T2 (de)	2006-11-16
CY1107985T1 (el)	2013-09-04

Publication	Publication Date	Title
IL210046A0 (en)	2011-07-31	Ccr1 antagonists for the treatment of i.a. demyelinating inflammatory disease
DK1522314T3 (da)	2014-05-26	Midler for sygdomme forårsaget af vaskulær sammentrækning eller udvidelse
DK1474416T3 (da)	2008-01-14	Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser
DK1633726T3 (da)	2011-03-28	Pyrimidinderivater, der er egnede til behandling af CRTH2-formidlede sygdomme
DE60324946D1 (de)	2009-01-08	Mehrlagiger vliesstoff
IS7099A (is)	2004-01-08	Efnasambönd til að meðhöndla bólgutruflanir
DK1562932T3 (da)	2007-08-13	4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
DK1643998T3 (da)	2007-12-27	NK1/NK3-antagonister til behandling af skizofreni
NO20053211D0 (no)	2005-06-30	Forbindelser for behandling av metabolske forstyrrelser.
DK1592384T3 (da)	2012-12-17	Cop 1 til behandling af inflammatoriske tarmsygdomme
BR0315742B1 (pt)	2011-03-09	conjunto de filtro.
FI20021631A0 (fi)	2002-09-12	Suodatinlaatta
DK1487828T3 (da)	2009-02-02	Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
DK1596870T4 (da)	2011-06-14	Højdosis-ibandronatformulering
DE60332816D1 (de)	2010-07-15	Nk1-antagonisten
DK1687297T3 (da)	2014-09-22	Triazindimerer til behandling af autoimmunsygdomme
DK2845594T3 (da)	2022-03-07	Anvendelse af dihydroimidazoloner til behandlingen af hunde.
ES1051856Y (es)	2003-02-01	Burlete perfeccionado.
DK1592417T3 (da)	2007-08-06	Kombinationen af antidiabetiske lægemidler
DE50204133D1 (de)	2005-10-06	Sektionaltor und führungsanordnung dafür
ES1053443Y (es)	2003-08-01	Pijama perfeccionado.
ITMI20022263A1 (it)	2004-04-26	Composizioni per il trattamento delle emorroidi.
ES1052866Y (es)	2003-06-01	Tendedero extensible perfeccionado.
ITMI20022188A1 (it)	2004-04-16	Apparecchiatura automatica per l'applicazione dell'intonaco.
BR8302526Y1 (pt)	2012-07-24	articulador multifuncional.